Johanna Auriau Selected Research

Neoplasms (Cancer)

9/2022	Upregulated Apelin Signaling in Pancreatic Cancer Activates Oncogenic Signaling Pathways to Promote Tumor Development.
12/2018	Gain of affinity for VEGF165 binding within the VEGFR2/NRP1 cellular complex detected by an HTRF-based binding assay.
1/2014	Development of a human breast-cancer derived cell line stably expressing a bioluminescence resonance energy transfer (BRET)-based phosphatidyl inositol-3 phosphate (PIP3) biosensor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johanna Auriau Research Topics

Disease

3	Neoplasms (Cancer) 09/2022 - 01/2014
2	Inflammation (Inflammations) 01/2021 - 01/2019
1	Adenocarcinoma 09/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2022
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 01/2021
1	Obesity 01/2021
1	Insulin Resistance 01/2021
1	Chronic Renal Insufficiency 01/2019
1	Hypertrophy 01/2019
1	Sarcopenia 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2014

Drug/Important Bio-Agent (IBA)

2	ApelinIBA 09/2022 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 01/2021
1	Proteins (Proteins, Gene)FDA Link 09/2022
1	Cyclin D1IBA 09/2022
1	CateninsIBA 09/2022
1	Apelin ReceptorsIBA 09/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 01/2021
1	LipidsIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	CollagenIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2014
1	Cetuximab (Erbitux)FDA Link 01/2014
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	Monoclonal AntibodiesIBA 01/2014
1	Epidermal Growth Factor (EGF)IBA 01/2014
1	Insulin (Novolin)FDA Link 01/2014
1	Phosphates (Orthophosphate)IBA 01/2014
1	Renilla LuciferasesIBA 01/2014
1	tyrphostin AG 1024IBA 01/2014

Therapy/Procedure

2	Therapeutics 09/2022 - 12/2018